The tumor-promoting impact of EIF3B was found to be mediated through PCNA, and the inhibition of PCNA not only suppressed the development of cholangiocarcinoma but also reversed the promotional effects induced by EIF3B overexpression. The gene discussed is PCNA; the disease is neoplasm.